As of 2025-12-26, the Intrinsic Value of Athira Pharma Inc (ATHA) is -84.39 USD. This Athira valuation is based on the model Peter Lynch Fair Value. With the current market price of 7.21 USD, the upside of Athira Pharma Inc is -1,270.44%.
Based on its market price of 7.21 USD and our intrinsic valuation, Athira Pharma Inc (ATHA) is overvalued by 1,270.44%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -84.39 - -84.39 | -84.39 | -1,270.44% |
| P/E | (196.80) - (271.06) | (262.87) | -3745.9% |
| DDM - Stable | (146.42) - (459.61) | (303.02) | -4302.7% |
| DDM - Multi | (354.03) - (868.80) | (503.58) | -7084.5% |
| Market Cap (mil) | 16.11 |
| Beta | 1.86 |
| Outstanding shares (mil) | 2.24 |
| Enterprise Value (mil) | -4.76 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.69% |
| Cost of Debt | 5.00% |
| WACC | 6.68% |